Global Gene Therapy for CNS Disorders Market Growth (Status and Outlook) 2025-2031
According to this study, the global Gene Therapy for CNS Disorders market size will reach US$ million by 2031.
Gene Therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gene Therapy for CNS Disorders Industry Forecast” looks at past sales and reviews total world Gene Therapy for CNS Disorders sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapy for CNS Disorders sales for 2025 through 2031. With Gene Therapy for CNS Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy for CNS Disorders industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy for CNS Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy for CNS Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy for CNS Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy for CNS Disorders and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy for CNS Disorders.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy for CNS Disorders market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene Therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gene Therapy for CNS Disorders Industry Forecast” looks at past sales and reviews total world Gene Therapy for CNS Disorders sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapy for CNS Disorders sales for 2025 through 2031. With Gene Therapy for CNS Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy for CNS Disorders industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy for CNS Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy for CNS Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy for CNS Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy for CNS Disorders and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy for CNS Disorders.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy for CNS Disorders market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Ex Vivo
- In Vivo
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead (Kite Pharma)
- Amgen (BioVex)
- Novartis
- Roche (Spark Therapeutics)
- Bluebird Bio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy for CNS Disorders Market Size (2020-2031)
2.1.2 Gene Therapy for CNS Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Therapy for CNS Disorders by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy for CNS Disorders Segment by Type
2.2.1 Ex Vivo
2.2.2 In Vivo
2.3 Gene Therapy for CNS Disorders Market Size by Type
2.3.1 Gene Therapy for CNS Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy for CNS Disorders Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Gene Therapy for CNS Disorders Market Size by Application
2.5.1 Gene Therapy for CNS Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
3 GENE THERAPY FOR CNS DISORDERS MARKET SIZE BY PLAYER
3.1 Gene Therapy for CNS Disorders Market Size Market Share by Player
3.1.1 Global Gene Therapy for CNS Disorders Revenue by Player (2020-2025)
3.1.2 Global Gene Therapy for CNS Disorders Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy for CNS Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY FOR CNS DISORDERS BY REGION
4.1 Gene Therapy for CNS Disorders Market Size by Region (2020-2025)
4.2 Global Gene Therapy for CNS Disorders Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy for CNS Disorders Market Size Growth (2020-2025)
4.4 APAC Gene Therapy for CNS Disorders Market Size Growth (2020-2025)
4.5 Europe Gene Therapy for CNS Disorders Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy for CNS Disorders Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Therapy for CNS Disorders Market Size by Country (2020-2025)
5.2 Americas Gene Therapy for CNS Disorders Market Size by Type (2020-2025)
5.3 Americas Gene Therapy for CNS Disorders Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy for CNS Disorders Market Size by Region (2020-2025)
6.2 APAC Gene Therapy for CNS Disorders Market Size by Type (2020-2025)
6.3 APAC Gene Therapy for CNS Disorders Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy for CNS Disorders Market Size by Country (2020-2025)
7.2 Europe Gene Therapy for CNS Disorders Market Size by Type (2020-2025)
7.3 Europe Gene Therapy for CNS Disorders Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy for CNS Disorders by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY FOR CNS DISORDERS MARKET FORECAST
10.1 Global Gene Therapy for CNS Disorders Forecast by Region (2026-2031)
10.1.1 Global Gene Therapy for CNS Disorders Forecast by Region (2026-2031)
10.1.2 Americas Gene Therapy for CNS Disorders Forecast
10.1.3 APAC Gene Therapy for CNS Disorders Forecast
10.1.4 Europe Gene Therapy for CNS Disorders Forecast
10.1.5 Middle East & Africa Gene Therapy for CNS Disorders Forecast
10.2 Americas Gene Therapy for CNS Disorders Forecast by Country (2026-2031)
10.2.1 United States Market Gene Therapy for CNS Disorders Forecast
10.2.2 Canada Market Gene Therapy for CNS Disorders Forecast
10.2.3 Mexico Market Gene Therapy for CNS Disorders Forecast
10.2.4 Brazil Market Gene Therapy for CNS Disorders Forecast
10.3 APAC Gene Therapy for CNS Disorders Forecast by Region (2026-2031)
10.3.1 China Gene Therapy for CNS Disorders Market Forecast
10.3.2 Japan Market Gene Therapy for CNS Disorders Forecast
10.3.3 Korea Market Gene Therapy for CNS Disorders Forecast
10.3.4 Southeast Asia Market Gene Therapy for CNS Disorders Forecast
10.3.5 India Market Gene Therapy for CNS Disorders Forecast
10.3.6 Australia Market Gene Therapy for CNS Disorders Forecast
10.4 Europe Gene Therapy for CNS Disorders Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Therapy for CNS Disorders Forecast
10.4.2 France Market Gene Therapy for CNS Disorders Forecast
10.4.3 UK Market Gene Therapy for CNS Disorders Forecast
10.4.4 Italy Market Gene Therapy for CNS Disorders Forecast
10.4.5 Russia Market Gene Therapy for CNS Disorders Forecast
10.5 Middle East & Africa Gene Therapy for CNS Disorders Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Therapy for CNS Disorders Forecast
10.5.2 South Africa Market Gene Therapy for CNS Disorders Forecast
10.5.3 Israel Market Gene Therapy for CNS Disorders Forecast
10.5.4 Turkey Market Gene Therapy for CNS Disorders Forecast
10.6 Global Gene Therapy for CNS Disorders Forecast by Type (2026-2031)
10.7 Global Gene Therapy for CNS Disorders Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Therapy for CNS Disorders Forecast
11 KEY PLAYERS ANALYSIS
11.1 Gilead (Kite Pharma)
11.1.1 Gilead (Kite Pharma) Company Information
11.1.2 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Product Offered
11.1.3 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Gilead (Kite Pharma) Main Business Overview
11.1.5 Gilead (Kite Pharma) Latest Developments
11.2 Amgen (BioVex)
11.2.1 Amgen (BioVex) Company Information
11.2.2 Amgen (BioVex) Gene Therapy for CNS Disorders Product Offered
11.2.3 Amgen (BioVex) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Amgen (BioVex) Main Business Overview
11.2.5 Amgen (BioVex) Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Gene Therapy for CNS Disorders Product Offered
11.3.3 Novartis Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Information
11.4.2 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Product Offered
11.4.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Roche (Spark Therapeutics) Main Business Overview
11.4.5 Roche (Spark Therapeutics) Latest Developments
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Information
11.5.2 Bluebird Bio Gene Therapy for CNS Disorders Product Offered
11.5.3 Bluebird Bio Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bluebird Bio Main Business Overview
11.5.5 Bluebird Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy for CNS Disorders Market Size (2020-2031)
2.1.2 Gene Therapy for CNS Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Therapy for CNS Disorders by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy for CNS Disorders Segment by Type
2.2.1 Ex Vivo
2.2.2 In Vivo
2.3 Gene Therapy for CNS Disorders Market Size by Type
2.3.1 Gene Therapy for CNS Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy for CNS Disorders Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Gene Therapy for CNS Disorders Market Size by Application
2.5.1 Gene Therapy for CNS Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
3 GENE THERAPY FOR CNS DISORDERS MARKET SIZE BY PLAYER
3.1 Gene Therapy for CNS Disorders Market Size Market Share by Player
3.1.1 Global Gene Therapy for CNS Disorders Revenue by Player (2020-2025)
3.1.2 Global Gene Therapy for CNS Disorders Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy for CNS Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY FOR CNS DISORDERS BY REGION
4.1 Gene Therapy for CNS Disorders Market Size by Region (2020-2025)
4.2 Global Gene Therapy for CNS Disorders Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy for CNS Disorders Market Size Growth (2020-2025)
4.4 APAC Gene Therapy for CNS Disorders Market Size Growth (2020-2025)
4.5 Europe Gene Therapy for CNS Disorders Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy for CNS Disorders Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Therapy for CNS Disorders Market Size by Country (2020-2025)
5.2 Americas Gene Therapy for CNS Disorders Market Size by Type (2020-2025)
5.3 Americas Gene Therapy for CNS Disorders Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy for CNS Disorders Market Size by Region (2020-2025)
6.2 APAC Gene Therapy for CNS Disorders Market Size by Type (2020-2025)
6.3 APAC Gene Therapy for CNS Disorders Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy for CNS Disorders Market Size by Country (2020-2025)
7.2 Europe Gene Therapy for CNS Disorders Market Size by Type (2020-2025)
7.3 Europe Gene Therapy for CNS Disorders Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy for CNS Disorders by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY FOR CNS DISORDERS MARKET FORECAST
10.1 Global Gene Therapy for CNS Disorders Forecast by Region (2026-2031)
10.1.1 Global Gene Therapy for CNS Disorders Forecast by Region (2026-2031)
10.1.2 Americas Gene Therapy for CNS Disorders Forecast
10.1.3 APAC Gene Therapy for CNS Disorders Forecast
10.1.4 Europe Gene Therapy for CNS Disorders Forecast
10.1.5 Middle East & Africa Gene Therapy for CNS Disorders Forecast
10.2 Americas Gene Therapy for CNS Disorders Forecast by Country (2026-2031)
10.2.1 United States Market Gene Therapy for CNS Disorders Forecast
10.2.2 Canada Market Gene Therapy for CNS Disorders Forecast
10.2.3 Mexico Market Gene Therapy for CNS Disorders Forecast
10.2.4 Brazil Market Gene Therapy for CNS Disorders Forecast
10.3 APAC Gene Therapy for CNS Disorders Forecast by Region (2026-2031)
10.3.1 China Gene Therapy for CNS Disorders Market Forecast
10.3.2 Japan Market Gene Therapy for CNS Disorders Forecast
10.3.3 Korea Market Gene Therapy for CNS Disorders Forecast
10.3.4 Southeast Asia Market Gene Therapy for CNS Disorders Forecast
10.3.5 India Market Gene Therapy for CNS Disorders Forecast
10.3.6 Australia Market Gene Therapy for CNS Disorders Forecast
10.4 Europe Gene Therapy for CNS Disorders Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Therapy for CNS Disorders Forecast
10.4.2 France Market Gene Therapy for CNS Disorders Forecast
10.4.3 UK Market Gene Therapy for CNS Disorders Forecast
10.4.4 Italy Market Gene Therapy for CNS Disorders Forecast
10.4.5 Russia Market Gene Therapy for CNS Disorders Forecast
10.5 Middle East & Africa Gene Therapy for CNS Disorders Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Therapy for CNS Disorders Forecast
10.5.2 South Africa Market Gene Therapy for CNS Disorders Forecast
10.5.3 Israel Market Gene Therapy for CNS Disorders Forecast
10.5.4 Turkey Market Gene Therapy for CNS Disorders Forecast
10.6 Global Gene Therapy for CNS Disorders Forecast by Type (2026-2031)
10.7 Global Gene Therapy for CNS Disorders Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Therapy for CNS Disorders Forecast
11 KEY PLAYERS ANALYSIS
11.1 Gilead (Kite Pharma)
11.1.1 Gilead (Kite Pharma) Company Information
11.1.2 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Product Offered
11.1.3 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Gilead (Kite Pharma) Main Business Overview
11.1.5 Gilead (Kite Pharma) Latest Developments
11.2 Amgen (BioVex)
11.2.1 Amgen (BioVex) Company Information
11.2.2 Amgen (BioVex) Gene Therapy for CNS Disorders Product Offered
11.2.3 Amgen (BioVex) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Amgen (BioVex) Main Business Overview
11.2.5 Amgen (BioVex) Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Gene Therapy for CNS Disorders Product Offered
11.3.3 Novartis Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Information
11.4.2 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Product Offered
11.4.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Roche (Spark Therapeutics) Main Business Overview
11.4.5 Roche (Spark Therapeutics) Latest Developments
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Information
11.5.2 Bluebird Bio Gene Therapy for CNS Disorders Product Offered
11.5.3 Bluebird Bio Gene Therapy for CNS Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bluebird Bio Main Business Overview
11.5.5 Bluebird Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy for CNS Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy for CNS Disorders Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ex Vivo
Table 4. Major Players of In Vivo
Table 5. Gene Therapy for CNS Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Table 8. Gene Therapy for CNS Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Therapy for CNS Disorders Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Therapy for CNS Disorders Revenue Market Share by Player (2020-2025)
Table 13. Gene Therapy for CNS Disorders Key Players Head office and Products Offered
Table 14. Gene Therapy for CNS Disorders Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy for CNS Disorders Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Therapy for CNS Disorders Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Therapy for CNS Disorders Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Therapy for CNS Disorders Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Therapy for CNS Disorders Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Therapy for CNS Disorders Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Therapy for CNS Disorders Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Therapy for CNS Disorders Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Therapy for CNS Disorders Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Therapy for CNS Disorders Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Therapy for CNS Disorders Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy for CNS Disorders
Table 39. Key Market Challenges & Risks of Gene Therapy for CNS Disorders
Table 40. Key Industry Trends of Gene Therapy for CNS Disorders
Table 41. Global Gene Therapy for CNS Disorders Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Therapy for CNS Disorders Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Therapy for CNS Disorders Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Gilead (Kite Pharma) Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 46. Gilead (Kite Pharma) Gene Therapy for CNS Disorders Product Offered
Table 47. Gilead (Kite Pharma) Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Gilead (Kite Pharma) Main Business
Table 49. Gilead (Kite Pharma) Latest Developments
Table 50. Amgen (BioVex) Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 51. Amgen (BioVex) Gene Therapy for CNS Disorders Product Offered
Table 52. Amgen (BioVex) Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Amgen (BioVex) Main Business
Table 54. Amgen (BioVex) Latest Developments
Table 55. Novartis Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 56. Novartis Gene Therapy for CNS Disorders Product Offered
Table 57. Novartis Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Roche (Spark Therapeutics) Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 61. Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Product Offered
Table 62. Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Roche (Spark Therapeutics) Main Business
Table 64. Roche (Spark Therapeutics) Latest Developments
Table 65. Bluebird Bio Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 66. Bluebird Bio Gene Therapy for CNS Disorders Product Offered
Table 67. Bluebird Bio Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Bluebird Bio Main Business
Table 69. Bluebird Bio Latest Developments
Table 1. Gene Therapy for CNS Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy for CNS Disorders Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ex Vivo
Table 4. Major Players of In Vivo
Table 5. Gene Therapy for CNS Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Table 8. Gene Therapy for CNS Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Therapy for CNS Disorders Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Therapy for CNS Disorders Revenue Market Share by Player (2020-2025)
Table 13. Gene Therapy for CNS Disorders Key Players Head office and Products Offered
Table 14. Gene Therapy for CNS Disorders Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy for CNS Disorders Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Therapy for CNS Disorders Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Therapy for CNS Disorders Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Therapy for CNS Disorders Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Therapy for CNS Disorders Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Therapy for CNS Disorders Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Therapy for CNS Disorders Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Therapy for CNS Disorders Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Therapy for CNS Disorders Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Therapy for CNS Disorders Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Therapy for CNS Disorders Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy for CNS Disorders
Table 39. Key Market Challenges & Risks of Gene Therapy for CNS Disorders
Table 40. Key Industry Trends of Gene Therapy for CNS Disorders
Table 41. Global Gene Therapy for CNS Disorders Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Therapy for CNS Disorders Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Therapy for CNS Disorders Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Gilead (Kite Pharma) Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 46. Gilead (Kite Pharma) Gene Therapy for CNS Disorders Product Offered
Table 47. Gilead (Kite Pharma) Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Gilead (Kite Pharma) Main Business
Table 49. Gilead (Kite Pharma) Latest Developments
Table 50. Amgen (BioVex) Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 51. Amgen (BioVex) Gene Therapy for CNS Disorders Product Offered
Table 52. Amgen (BioVex) Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Amgen (BioVex) Main Business
Table 54. Amgen (BioVex) Latest Developments
Table 55. Novartis Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 56. Novartis Gene Therapy for CNS Disorders Product Offered
Table 57. Novartis Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Roche (Spark Therapeutics) Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 61. Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Product Offered
Table 62. Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Roche (Spark Therapeutics) Main Business
Table 64. Roche (Spark Therapeutics) Latest Developments
Table 65. Bluebird Bio Details, Company Type, Gene Therapy for CNS Disorders Area Served and Its Competitors
Table 66. Bluebird Bio Gene Therapy for CNS Disorders Product Offered
Table 67. Bluebird Bio Gene Therapy for CNS Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Bluebird Bio Main Business
Table 69. Bluebird Bio Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy for CNS Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy for CNS Disorders Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy for CNS Disorders Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy for CNS Disorders Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy for CNS Disorders Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy for CNS Disorders Market Size Market Share by Type in 2024
Figure 10. Gene Therapy for CNS Disorders in Hospitals
Figure 11. Global Gene Therapy for CNS Disorders Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Gene Therapy for CNS Disorders in Clinics
Figure 13. Global Gene Therapy for CNS Disorders Market: Clinics (2020-2025) & ($ millions)
Figure 14. Gene Therapy for CNS Disorders in Others
Figure 15. Global Gene Therapy for CNS Disorders Market: Others (2020-2025) & ($ millions)
Figure 16. Global Gene Therapy for CNS Disorders Market Size Market Share by Application in 2024
Figure 17. Global Gene Therapy for CNS Disorders Revenue Market Share by Player in 2024
Figure 18. Global Gene Therapy for CNS Disorders Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gene Therapy for CNS Disorders Market Size 2020-2025 ($ millions)
Figure 20. APAC Gene Therapy for CNS Disorders Market Size 2020-2025 ($ millions)
Figure 21. Europe Gene Therapy for CNS Disorders Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gene Therapy for CNS Disorders Market Size 2020-2025 ($ millions)
Figure 23. Americas Gene Therapy for CNS Disorders Value Market Share by Country in 2024
Figure 24. United States Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gene Therapy for CNS Disorders Market Size Market Share by Region in 2024
Figure 29. APAC Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Figure 31. China Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gene Therapy for CNS Disorders Market Size Market Share by Country in 2024
Figure 38. Europe Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 54. APAC Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 55. Europe Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 57. United States Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 58. Canada Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 61. China Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 62. Japan Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 63. Korea Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 65. India Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 66. Australia Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 67. Germany Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 68. France Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 69. UK Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 70. Italy Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 71. Russia Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 74. Israel Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 76. Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 1. Gene Therapy for CNS Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy for CNS Disorders Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy for CNS Disorders Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy for CNS Disorders Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy for CNS Disorders Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy for CNS Disorders Market Size Market Share by Type in 2024
Figure 10. Gene Therapy for CNS Disorders in Hospitals
Figure 11. Global Gene Therapy for CNS Disorders Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Gene Therapy for CNS Disorders in Clinics
Figure 13. Global Gene Therapy for CNS Disorders Market: Clinics (2020-2025) & ($ millions)
Figure 14. Gene Therapy for CNS Disorders in Others
Figure 15. Global Gene Therapy for CNS Disorders Market: Others (2020-2025) & ($ millions)
Figure 16. Global Gene Therapy for CNS Disorders Market Size Market Share by Application in 2024
Figure 17. Global Gene Therapy for CNS Disorders Revenue Market Share by Player in 2024
Figure 18. Global Gene Therapy for CNS Disorders Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gene Therapy for CNS Disorders Market Size 2020-2025 ($ millions)
Figure 20. APAC Gene Therapy for CNS Disorders Market Size 2020-2025 ($ millions)
Figure 21. Europe Gene Therapy for CNS Disorders Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gene Therapy for CNS Disorders Market Size 2020-2025 ($ millions)
Figure 23. Americas Gene Therapy for CNS Disorders Value Market Share by Country in 2024
Figure 24. United States Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gene Therapy for CNS Disorders Market Size Market Share by Region in 2024
Figure 29. APAC Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Figure 31. China Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gene Therapy for CNS Disorders Market Size Market Share by Country in 2024
Figure 38. Europe Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gene Therapy for CNS Disorders Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gene Therapy for CNS Disorders Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 54. APAC Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 55. Europe Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 57. United States Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 58. Canada Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 61. China Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 62. Japan Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 63. Korea Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 65. India Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 66. Australia Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 67. Germany Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 68. France Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 69. UK Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 70. Italy Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 71. Russia Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 74. Israel Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
Figure 76. Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gene Therapy for CNS Disorders Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gene Therapy for CNS Disorders Market Size 2026-2031 ($ millions)
